In 2000, the first domestic peptide product research and development center was established.
In 2001, the independently developed bioactive peptide raw materials (intermediates) were listed as a major provincial project. In the same year, Shenzhen Hanyu Pharmaceutical Co., Ltd. was established with the approval of the State Food and Drug Administration.
In 2002, the peptide drug production base was listed as the "Shenzhen High-tech Industrialization Demonstration Project", and was approved by the Shenzhen Municipal Government to build a peptide drug production base in the Shenzhen High-tech Zone; it was also listed as a Shenzhen City Major construction projects; the peptide product research and development center is listed as the Shenzhen Engineering Technology R&D Center; and has undertaken the national "863" plan projects and the national "10th Five-Year Plan" major scientific and technological projects.
In 2003, the polypeptide drug production base successfully passed the acceptance inspection of the national and provincial drug regulatory authorities and obtained the "Drug Production License" and "Drug GMP Certificate"; at the same time, it undertook key breakthrough projects in key fields in Guangdong Province.
In 2004, the peptide drug production base was listed as a "National High-tech Industrialization Demonstration Project"; some peptide drugs entered large-scale production and sales.
In 2005, the national "863" project and the national "Tenth Five-Year Plan" major science and technology projects undertaken by the company successfully passed the acceptance of the Ministry of Science and Technology; the peptide R&D center was listed as the Guangdong Provincial Engineering Technology Research and Development Center.
In 2006, the national high-tech new peptide drug industrialization demonstration project undertaken by the company successfully passed the acceptance of the National Development and Reform Commission.
In 2007, the peptide drug export base was listed as a "National High-tech Industrialization Demonstration Project"; it successfully passed the inspection of the "Third On-site Meeting on National Product Quality and Food Safety Special Rectification"; and undertook national "Eleventh Five-Year Plan" major science and technology projects; Hanyu Pharmaceutical was selected as one of the "Top 100 Most Promising Science and Technology Enterprises in China" in 2007; won the title of "Shenzhen Science and Technology Innovation Award" and "Shenzhen Leading Enterprise in Independent Innovation Industry" .
In 2008, Hanyu Pharmaceutical entered into strategic cooperation with SoftBank SAIF Asia Investment Fund and Shenzhen Innovation Investment Group, investing US$15 million in the first phase of Hanyu Pharmaceutical; the research and development of polypeptide drug engineering technology in Guangdong Province The center successfully passed the acceptance inspection; the company was selected as one of the "2008 Deloitte High-tech, Fast-Growing China's Top 50" enterprises.
On October 28, 2009, the company officially changed its name to "Shenzhen Hanyu Pharmaceutical Co., Ltd." and was recognized as a "National High-tech Enterprise"; it has undertaken and participated in 3 "National Major New Drugs" Created” major science and technology projects, 2 national high-tech industrialization projects; won the “Second Prize of Guangdong Province Science and Technology Award”.
In 2010, it was awarded the title of "National High-tech New Peptide Drug Industrialization Demonstration Project" by the National Development and Reform Commission; selected as one of "Top 200 Chinese Potential Enterprises in 2010" by Forbes magazine; selected as one of "Deloitte Asia Pacific High Growth Enterprises" "Top 500"; successfully completed the shareholding reform and entered the GEM listing approval stage.
In 2011, with the approval of the China Securities Regulatory Commission, Hanyu Pharmaceutical issued shares for the first time and was listed on the GEM, becoming the first synthetic peptide stock in my country; it was rated as "Top 500 Enterprises in Guangdong Province in 2011"; R&D The center was recognized as a “National and Local Joint Engineering Laboratory” by the National Development and Reform Commission.
In 2012, it was selected into the "2012 Forbes China's Most Potential Enterprises List".
In 2013, it was selected into the "2013 Forbes China's Most Potential Enterprises List".